These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2295592)

  • 1. Increased plasma nortriptyline concentration in a patient cotreated with fluoxetine.
    Kahn DG
    J Clin Psychiatry; 1990 Jan; 51(1):36. PubMed ID: 2295592
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoxetine and nortriptyline combination therapy.
    Schraml F; Benedetti G; Hoyle K; Clayton A
    Am J Psychiatry; 1989 Dec; 146(12):1636-7. PubMed ID: 2589560
    [No Abstract]   [Full Text] [Related]  

  • 3. Venlafaxine-fluoxetine-nortriptyline interaction.
    Benazzi F
    J Psychiatry Neurosci; 1997 Jul; 22(4):278-9. PubMed ID: 9262050
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of fluoxetine with carbamazepine.
    Pearson HJ
    J Clin Psychiatry; 1990 Mar; 51(3):126. PubMed ID: 2353956
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports.
    Michals M; Stanley DA; Crismon ML; Barrow NE
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):466-7. PubMed ID: 2136405
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine.
    Downs JM; Downs AD; Rosenthal TL; Deal N; Akiskal HS
    J Clin Psychiatry; 1989 Jun; 50(6):226-7. PubMed ID: 2785987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine and sumatriptan: possibly a counterproductive combination.
    Szabo CP
    J Clin Psychiatry; 1995 Jan; 56(1):37-8. PubMed ID: 7836342
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment outcome in elderly depressives: plasma nortriptyline concentration and pretreatment dexamethasone suppression test.
    Young RC; Alexopoulos GS; Manley MW; Shamoian CA; Dhar AK; Kutt H
    Adv Biochem Psychopharmacol; 1984; 39():207-11. PubMed ID: 6464830
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent fluoxetine treatment and complications of tricyclic therapy.
    Extein IL
    Am J Psychiatry; 1991 Nov; 148(11):1601-2. PubMed ID: 1928480
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation of plasma amitriptyline and nortriptyline levels to the therapeutic response in endogenous depression].
    Garaj V; Frank V; Drímalová M; Móric R; Pullmann R
    Cesk Psychiatr; 1986 Oct; 82(5):307-12. PubMed ID: 3791462
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine-nortriptyline therapy of treatment-resistant major depression in a geriatric patient.
    Rothschild BS
    J Geriatr Psychiatry Neurol; 1994; 7(3):137-8. PubMed ID: 7916935
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Roberts RL; Mulder RT; Joyce PR; Luty SE; Kennedy MA
    Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
    Vandel S; Bertschy G; Jounet JM; Allers G
    Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.
    Roberts RL; Joyce PR; Mulder RT; Begg EJ; Kennedy MA
    Pharmacogenomics J; 2002; 2(3):191-6. PubMed ID: 12082591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activity.
    Rephaeli A; Gil-Ad I; Aharoni A; Tarasenko I; Tarasenko N; Geffen Y; Halbfinger E; Nisemblat Y; Weizman A; Nudelman A
    J Med Chem; 2009 May; 52(9):3010-7. PubMed ID: 19378992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose fluoxetine in management of premenstrual syndrome.
    Daamen MJ; Brown WA
    J Clin Psychiatry; 1992 Jun; 53(6):210-1. PubMed ID: 1607351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.